In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...
Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures. The seed fund will be used to redesign the failure-prone ...
— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK--(BUSINESS ...
LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--Turbine, a simulation-based drug discovery company today announced the closing of an institutional financing round led by Delin Ventures. The seed fund ...
Innovative Science in the Areas of Small Molecule Modeling, Fragment-Based Design, Transmembrane Proteins, and Antibody Modeling Sets New Standard for Life Science Research and Development SAN DIEGO, ...
A simulation-based drug discovery company, Turbine, has announced the closing of an institutional funding round worth EUR 3 million (US $3.3 million), which will be used to redesign the oncology drug ...
News: HCLTech joins Microsoft Discovery, an agentic AI platform, to accelerate breakthroughs across materials science, drug ...
Turbine, a simulation-based drug discovery company has announced the closing of an institutional financing round; the seed fund will be used to redesign the failure-prone oncology drug discovery ...
What would happen if (when?) a 310-mile-wide asteroid collides with Earth? That’s the fun question behind the simulation in the video below. And the answer is ...
WILMINGTON, N.C. (WECT) - Cape Fear Community College (CFCC) will host a Career Discovery Night this month, focusing on the Simulation and Game Development program. According to CFCC, attendees will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback